ENDRA is a medical technology company based in Ann Arbor, MI, specializing in the early detection and monitoring of liver disease. Their innovative TAEUS (Thermo Acoustic Enhanced Ultrasound) liver device offers a non-invasive and cost-effective solution for measuring liver fat, a key indicator of conditions such as Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). With the potential to revolutionize the clinical care cycle of liver disease, ENDRA's TAEUS technology aims to improve the health outcomes of millions of people worldwide.
By combining radio frequency and ultrasound, TAEUS provides clinicians with a quick and accurate measurement of liver fat in less than a minute, enabling early diagnosis and intervention. With its CE-marked status for sale in Europe and ongoing efforts for FDA approval in the US, ENDRA is at the forefront of developing accessible and safe tools for diagnosing liver diseases, ultimately reducing healthcare costs associated with advanced stages of the condition. In addition to liver disease applications, TAEUS has the potential to be utilized in various other medical fields, such as visualizing tissue temperature during surgery and identifying arterial plaque or internal bleeding.
Generated from the website
